Selective Inhibition of Histone Deacetylase 10: Hydrogen Bonding to the Gatekeeper Residue is Implicated
Authors:
- Magalie GéraldyMGMagalie Géraldy
- Michael MorgenMMMichael Morgen
- Davide MoiDMDavide Moi
- Mona MalzMMMona Malz
- Oliver KochOKOliver Koch
- 9 April 2019
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 62 (9) , 4426-4443
Abstract
The discovery of isozyme-selective histone deacetylase (HDAC) inhibitors is critical for understanding the biological functions of individual HDACs and for validating HDACs as drug targets. The isozyme HDAC10 contributes to chemotherapy resistance and has recently been described to be a polyamine deacetylase, but no studies toward selective HDAC10 inhibitors have been published. Using two complementary assays, we found tubastatin A, an HDAC6 inhibitor, to potently bind HDAC10. We synthesized tubastatin A derivatives and found that a basic amine in the cap group was required for strong HDAC10 binding. HDAC10 inhibitors mimicked knockdown by causing dose-dependent accumulation of acidic vesicles in a neuroblastoma cell line. Furthermore, docking into human HDAC10 homology models indicated that a hydrogen-bond between a cap group nitrogen and the gatekeeper residue Glu272 was responsible for potent HDAC10 binding. Taken together, our data provide an optimal platform for the development of HDAC10-selective inhibitors, as exemplified with the tubastatin A scaffold.Keywords
All Related Versions
Funding Information
- Bundesministerium f?r Bildung und Forschung (BMBF 1316053)
- Helmholtz-Gemeinschaft
- German Cancer Consortium
- Mercator Research Center Ruhr (AN-2015-0053)
This publication has 47 references indexed in Scilit:
- Histone Deacetylase 11 Is an ε-N-Myristoyllysine HydrolaseCell Chemical Biology, 2018
- Histone Deacetylase 11 Is a Fatty-Acid DeacylaseACS Chemical Biology, 2018
- Histone deacetylase 10 structure and molecular function as a polyamine deacetylaseNature Communications, 2017
- Inside HDACs with more selective HDAC inhibitorsEuropean Journal of Medicinal Chemistry, 2016
- HDAC8 Catalyzes the Hydrolysis of Long Chain Fatty Acyl LysineACS Chemical Biology, 2016
- Histone deacetylases and their inhibitors in cancer, neurological diseases and immune disordersNature Reviews Drug Discovery, 2014
- Activation of the Protein Deacetylase SIRT6 by Long-chain Fatty Acids and Widespread Deacylation by Mammalian SirtuinsJournal of Biological Chemistry, 2013
- Isoform-specific histone deacetylase inhibitors: The next step?Cancer Letters, 2009
- Dimethyl sulfoxide to vorinostat: development of this histone deacetylase inhibitor as an anticancer drugNature Biotechnology, 2007
- A Mammalian Histone Deacetylase Related to the Yeast Transcriptional Regulator Rpd3pScience, 1996